- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 4KO: (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: E.142, R.143, H.144
- Ligands: 4KO.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:H.144
- Salt bridges: A:H.144
SO4.3: 2 residues within 4Å:- Chain A: R.52, G.53
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:G.53
- Water bridges: A:R.52, A:G.53, A:S.54, A:S.54, A:Y.110
SO4.4: 3 residues within 4Å:- Chain A: A.141, R.143, Q.155
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.155
- Salt bridges: A:R.143
SO4.16: 8 residues within 4Å:- Chain A: G.91, L.92, G.93, V.94, A.95, R.96, L.129
- Ligands: EDO.8
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:G.91, A:G.93, A:G.93, A:V.94, A:A.95, A:R.96
- Water bridges: A:L.92
- Salt bridges: A:R.96
SO4.19: 4 residues within 4Å:- Chain B: E.142, R.143, H.144
- Ligands: 4KO.18
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:H.144
- Salt bridges: B:H.144
SO4.20: 2 residues within 4Å:- Chain B: R.52, G.53
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:G.53
- Water bridges: B:R.52, B:G.53, B:S.54, B:S.54, B:Y.110
SO4.21: 3 residues within 4Å:- Chain B: A.141, R.143, Q.155
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.155
- Salt bridges: B:R.143
SO4.33: 8 residues within 4Å:- Chain B: G.91, L.92, G.93, V.94, A.95, R.96, L.129
- Ligands: EDO.25
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:G.91, B:G.93, B:G.93, B:V.94, B:A.95, B:R.96
- Water bridges: B:L.92
- Salt bridges: B:R.96
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.5: 6 residues within 4Å:- Chain A: E.27, C.31, M.83, M.84, V.85, R.90
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: H.74, K.111, R.113
Ligand excluded by PLIPEDO.7: 2 residues within 4Å:- Chain A: P.146, D.147
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: N.123, A.125, G.126
- Ligands: SO4.16
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: Y.70, Q.71, W.72, Q.73
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.52, W.72
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: R.25, D.26, F.29, D.145, V.151
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: E.11, T.12
- Ligands: EDO.13
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: A.10, T.12, L.15
- Ligands: EDO.12
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain A: Q.23, D.24
Ligand excluded by PLIPEDO.15: 2 residues within 4Å:- Chain A: G.20, Q.23
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain A: Y.32, K.34, A.47, E.50, R.51
- Ligands: 4KO.1
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain B: E.27, C.31, M.83, M.84, V.85, R.90
Ligand excluded by PLIPEDO.23: 3 residues within 4Å:- Chain B: H.74, K.111, R.113
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: P.146, D.147
Ligand excluded by PLIPEDO.25: 4 residues within 4Å:- Chain B: N.123, A.125, G.126
- Ligands: SO4.33
Ligand excluded by PLIPEDO.26: 4 residues within 4Å:- Chain B: Y.70, Q.71, W.72, Q.73
Ligand excluded by PLIPEDO.27: 2 residues within 4Å:- Chain B: R.52, W.72
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain B: R.25, D.26, F.29, D.145, V.151
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain B: E.11, T.12
- Ligands: EDO.30
Ligand excluded by PLIPEDO.30: 4 residues within 4Å:- Chain B: A.10, T.12, L.15
- Ligands: EDO.29
Ligand excluded by PLIPEDO.31: 2 residues within 4Å:- Chain B: Q.23, D.24
Ligand excluded by PLIPEDO.32: 2 residues within 4Å:- Chain B: G.20, Q.23
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain B: Y.32, K.34, A.47, E.50, R.51
- Ligands: 4KO.18
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majorek, K.A. et al., Structural, Functional, and Inhibition Studies of a Gcn5-related N-Acetyltransferase (GNAT) Superfamily Protein PA4794: A NEW C-TERMINAL LYSINE PROTEIN ACETYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA. J.Biol.Chem. (2013)
- Release Date
- 2013-06-05
- Peptides
- Uncharacterized protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.55 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 4KO: (6R,7S)-7-({[(cyanomethyl)sulfanyl]acetyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia -1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Majorek, K.A. et al., Structural, Functional, and Inhibition Studies of a Gcn5-related N-Acetyltransferase (GNAT) Superfamily Protein PA4794: A NEW C-TERMINAL LYSINE PROTEIN ACETYLTRANSFERASE FROM PSEUDOMONAS AERUGINOSA. J.Biol.Chem. (2013)
- Release Date
- 2013-06-05
- Peptides
- Uncharacterized protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A